Pulmonary function tests (PFT) are routinely used to assess lung function but they do not provide information about regional pulmonary dysfunction. We aimed to assess correlation of quantitative ventilation/perfusion (V/Q) PET/CT with PFT indices.
INTRODUCTION
Pulmonary function tests (PFTs) are simple, non-invasive and well-established physiological investigations that provide reliable information about global lung function (1) .
However, they may be insensitive for detection of early pulmonary dysfunction (2,3) and do not provide spatial information about regional pulmonary dysfunction (4) . Whilst PFTs measure the mechanics of gas exchange properties of the lungs, they provide limited information about pulmonary blood flow, a key component of gas exchange in the lung. Establishing a functional map of the regional ventilation and perfusion in the lungs is highly relevant to understanding the physiological features of the lungs in many clinical situations, including individualizing and adapting radiation therapy planning (5, 6) , predicting postoperative lung function after lung resection in lung cancer patients (7) or in predicting clinical outcomes after lung volume reduction surgery in patients with emphysema (8) .
The principle underlying Ventilation/Perfusion (V/Q) scintigraphy is very attractive for lung function assessment as it simultaneously assesses and compares the regional distribution of the two major determinants of gas exchange in the lungs. Ventilation is imaged following inhalation of inert gases or radiolabelled aerosols, such as 99m Tc-labelled aerosol (Technegas, Cyclopharm, Sydney, Australia), that reach terminal bronchioles in proportion to regional distribution of ventilation (9) . Perfusion is imaged following intravenous administration of 99m Tclabelled-macroaggregated albumin (MAA) particles, which are trapped in the lung capillaries so that local concentration is related to the regional pulmonary blood flow. However, the relatively low spatial and temporal resolution of conventional V/Q scintigraphy has limited accurate mapping and quantification of ventilation and perfusion functional volumes, and of their relationship throughout the lung (10,11).
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Our group has demonstrated the feasibility of transitioning from conventional single photon techniques to positron emission tomography (PET) technology for V/Q imaging (12) . 99m Technetium can be substituted by 68 Gallium, a positron-emitting radionuclide, to label the same carrier molecules as conventional V/Q imaging. Ventilation imaging can be performed with 68 Ga-carbon nanoparticles using the same synthesis device as Technegas, yielding "Galligas" (13) . Perfusion imaging can be performed with 68 Ga-MAA. As with others areas of nuclear medicine, PET offers a unique opportunity to dramatically improve the diagnostic performances of V/Q imaging due to its higher sensitivity, spatial resolution, speed of acquisition, and quantitative capability in comparison to conventional V/Q scan (14) (15) (16) (17) .
Because of these characteristics, high-resolution quantitative V/Q PET/CT imaging may provide new insights for lung function assessment. The aim of the study was to correlate key pulmonary function test indices with global lung functional volumes computed with V/Q PET/CT.
MATERIAL AND METHODS

Patients
Thirty consecutive patients (19 males, 11 females; mean age 65 years, range 46-89 years) were prospectively recruited. All had locally advanced or inoperable non-small-cell lung cancer and were planned to have radiation therapy with curative intent as part of a prospective study were previously included in a study that investigated the effects of respiratory motion on V/Q scanning (18) . The study was approved by the institutional ethics committee and all patients provided written informed consent. (1) . DLCO was also dichotomized according to the presence of severe impairment defined as DLCO <55% predicted (21) .
V/Q PET/CT protocol
All patients underwent a respiratory-gated V/Q PET/CT scan acquired on a GE Discovery 690 PET/CT scanner (GE Medical Systems Milwaukee, WI, USA) using a procedure that we have previously described (18) . Ventilation images were acquired following inhalation of Galligas prepared using a Technegas generator (Cyclopharm, Sydney, Australia). Perfusion images were acquired following intravenous administration of 68 Ga-MAA.
Volumetric assessment of ventilation and perfusion function with V/Q PET/CT
The lung functional volumes were contoured using MIMimage analysis software (MIM 5.4.4;
MIMSoftware, Cleveland, OH, USA).
Whole lung volume delineation
The phase of the respiratory cycle where the PET and CT images were best aligned was chosen for delineation. This was generally in the mid time expiratory phase of the breathing cycle. The whole lung (WL) was then delineated on the chosen CT scan. An automatic contouring of the by on August 28, 2017. For personal use only. jnm.snmjournals.org Downloaded from lungs based on Hounsfield unit value was initially performed, and then visually adjusted to match normal contours if required.
Ventilation and Perfusion volumes delineation
PET images were independently reviewed to delineate pulmonary regions with normal ventilation and normal perfusion. Areas of normal ventilation and perfusion were defined by a nuclear medicine physician experienced in reading V/Q imaging.
Combined Ventilation/Perfusion lung volumes calculation
The percentage of lung volume with normal and abnormal function was computed for several 
Statistical analysis
All statistical tests were carried out using GraphPad Prism 5 (La Jolla, CA, USA). The Spearman rank correlation test was used to calculate correlations between V/Q PET/CT functional volumes and PFTs indices. The two-tailed Mann-Whitney U and Kruskall-Wallis tests were used for comparison of differences between groups. The null hypothesis was rejected when p<0.05.
RESULTS
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The mean FEV1/FVC was 64% (range 34% -88%) and the mean FEV1 was 61% predicted (range 32% -126%). Eighteen patients (60%) had COPD (FEV1/FVC<70), with 7 GOLD stage I, 8 GOLD stage II, and 3 GOLD stage III. Mean FVC was 80% (range 58% -134%). DLCO was available in 29/30 patients. Mean DLCO was 63% predicted (range 27%-102%). DLCO was lower than 55% in 10 patients. 
Comparison of V/Q PET/CT functional volumes with PFT indices
FEV1
%NVQ also demonstrated the highest correlation with FEV1 (r =0.64) ( Figure 3B ). Figure 4B shows V/Q PET/CT functional profile in relation with the degree of obstruction according to GOLD. There was a significant difference according to the grade of the degree of obstructive syndrome (i.e. FEV1 >80, 50-80, or <50) with the percentage of lung volumes with normal perfusion, normal ventilation, normal ventilation and perfusion, and matched defects (p<0.05).
DLCO
The percentage of lung with unmatched defects (i.e. either mismatched or reverse mismatched defects) demonstrated highest correlation with DLCO (r=0.55) (FIGURE 3C). All V/Q PET/CT functional volumes were significantly different in patients with severe impairment of DLCO (DLCO<55% predicted) (p<0.05) (See FIGURE 4C).
FVC
No correlation was found between FVC and V/Q PET/CT functional volumes.
Comparison of V/Q PET/CT functional volumes with global lung function impairment
Considering %NVQ only, a cut-off value of 90% correctly categorized 28 of 30 patients (93%) with or without significant pulmonary function impairment (defined by confirmed chronic obstructive pulmonary disease or severe impairment of DLCO) (see FIGURE 5) . Eight patients had more than 90% of lung volume with normal ventilation and perfusion and all were free from significant pulmonary disease. Out of the 22 patients demonstrating less than 90% of lung volume with normal ventilation and perfusion, 20 (91%) had COPD and/or DLCO<55% predicted.
DISCUSSION
In the present study, we aimed to validate the regional functional information obtained from this new imaging tool with routine global pulmonary functional assessments. The regional matching of ventilation and perfusion is a key physiological principle governing efficient gas exchange by supports the validity of using regional measures of lung function derived using this technique in predicting the consequences of therapies that impact of regional function, such as surgery or radiotherapy. DLCO was best negatively correlated with the percentage of lung volume with unmatched defects, underpinning the importance of matched ventilation and perfusion to gas exchange. Overall, %NVQ higher than 90% correctly identified significant lung function impairment (defined by COPD or DLCO < 55%) in 93% of patients.
In the past decades, V/Q imaging has been an evolving technology with the introduction of SPECT imaging, the development of hybrid SPECT-CT devices and the use of new radiotracers for ventilation (22) . Advances have improved the diagnostic performances of the test especially in pulmonary embolism diagnosis (23, 24) , and also in lung functional assessment (25, 26) . However, relatively low resolution of SPECT imaging makes accurate delineation and quantification of lung functional volumes difficult (11) . The introduction of PET imaging has dramatically increased the possibilities of nuclear medicine imaging. The principles of SPECT and PET, both molecular imaging techniques that can evaluate physiological, biological and biochemical processes are similar, but current PET technology has clear technical superiority compared with SPECT, with higher sensitivity for detecting radioactive decay, higher resolution and superior quantitative capability (14) (15) (16) .
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The majority of patients studied in this cohort had underlying of COPD of varying severity. All V/Q PET/CT functional volumes were different in patients with COPD. The change of all functional volumes highlights the heterogeneity and complexity of the pathophysiology underlying COPD which affects proximal and peripheral airways, lung parenchyma, and pulmonary vasculature (27, 28) . Pathologic changes include structural changes resulting from repeated injury and repair in different parts of the lung and chronic inflammation (4) . Among all V/Q PET/CT functional volumes, the most relevant parameter in predicting the degree of obstruction was the %NVQ, with strong correlation with FEV1/FVC (r=0.82) and FEV1 (r=0.64).
This indicates that physiologic impairment due to matched or unmatched defects are associated with the pathologic changes related COPD and are involved in the pathophysiology of the obstructive syndrome as described by PFTs.
The correlation was weaker but still significant with DLCO. DLCO is an indicator of abnormal gas exchange, whose determinants are complex, involving both the function of alveolar membrane and pulmonary blood pool. The strongest correlation was with the percentage of lung volume with unmatched defects rather than with matched defects or normal function. For patients with DLCO greater than or less than 55, the mean percentage of unmatched volume was 7% and 15%, respectively (p<0.05). In this study, V/Q inhomogeneity was therefore an essential determinant of DLCO impairment.
Whilst PFTs enable assessment of global lung function, a key advantage of V/Q imaging is to assess regional lung function. In particular, V/Q PET/CT provides four physiological patterns which give information which could be physiologically and clinically important. There are many pulmonary conditions in which accurate imaging of regional changes in the lungs would be of high interest. This includes radiotherapy planning to minimise dose to functional lung in order
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decrease the risk of radiation pneumonitis (5,29), pre-surgical evaluation of patients undergoing bronchoscopic or surgical lung volume reduction surgery (8, 30) , and assessment of pulmonary reserve prior to pulmonary resection surgery (7) . Several imaging techniques have been proposed in that purpose (31, 32) 
